Advanced Lung Cancer Inflammation Index as a Prognostic Inflammation–Nutrition Marker in Appendiceal High‐Grade Pseudomyxoma Peritonei: A 10‐Year Single‐Center Study
- 1Department of Oncology Beijing Chao‐Yang Hospital, Capital Medical University Beijing China
- 2Department of General Practice Aerospace Center Hospital Beijing China
- 3Department of Myxoma Aerospace Center Hospital Beijing China
Abstract
Background: Pseudomyxoma peritonei (PMP) prognosis remains heterogeneous. Systemic inflammation and nutrition are linked to cancer survival, but their role in PMP is unclear. We aimed to evaluate the prognostic impact of inflammation–nutrition status in appendiceal high‐grade PMP and to develop and internally validate a perioperative prognostic model.
Methods: We retrospectively included patients with pathologically confirmed appendiceal high‐grade PMP who underwent cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC) between January 2015 and December 2024. Baseline variables included demographics, body mass index (BMI), tumor markers (CEA, CA19‐9, CA125), inflammation–nutrition indices (advanced lung cancer inflammation index [ALI], prognostic nutritional index [PNI], neutrophil‐to‐lymphocyte ratio [NLR], platelet‐to‐lymphocyte ratio [PLR], lymphocyte‐to‐monocyte ratio [LMR], systemic inflammation score [SIS], systemic immune–inflammation index [SII]), prior surgical score (PSS), peritoneal cancer index (PCI), completeness of cytoreduction (CC), HIPEC, pathological subtype, and Ki‐67. Overall survival (OS) was the primary endpoint. Prognostic factors were identified by univariable and multivariable Cox models, and a nomogram was developed and internally validated.
Results: Among 223 patients (146 females, 65.5%), median age was 59 years, and median OS was 21 months. In the multivariable Cox regression model, independent risk factors for worse overall survival (OS) were high‐grade with signet‐ring cells (hazard ratio [HR] = 2.575, 95% CI 1.749–3.790; p < 0.001), elevated CA19‐9 (HR = 2.189, 95% CI 1.501–3.192; p < 0.001), elevated CA125 (HR = 1.495, 95% CI 1.050–2.127; p = 0.026), high Ki‐67 (HR = 1.976, 95% CI 1.238–3.154; p = 0.004), and an unfavorable CC (CC1–3) (HR = 2.705, 95% CI 1.295–5.648; p = 0.008), while receipt of hyperthermic intraperitoneal chemotherapy (HIPEC) (HR = 0.611, 95% CI 0.377–0.991; p = 0.046) and a high ALI (HR = 0.576, 95% CI 0.398–0.834; p = 0.003) were independent protective factors. The model achieved a C‐index of 0.753, with 1‐, 2‐, and 3‐year AUCs of 0.810, 0.839, and 0.775, respectively. Calibration error was low (≈3%–6%) and decision‐curve analysis showed sustained net benefit across broad threshold ranges.
Conclusions: The ALI is an independent prognostic marker in appendiceal high‐grade PMP. A nomogram incorporating ALI with tumor and pathological variables enabled reliable perioperative survival prediction with strong discrimination, calibration, and clinical utility.
Related
- Clinicopathologic characteristics and molecular landscape for pseudomyxoma peritonei of appendiceal origin.
- Stromal COL12A1 defines a pro-invasive extracellular matrix niche in appendiceal mucinous neoplasms and pseudomyxoma peritonei
- Integrated Microbial Profiling Identifies Bacterial and Fungal Communities in Pseudomyxoma Peritonei Mucin.
- A prognostic inflammation-nutrition reserve index for 180-day functional-survival outcomes after acute ischemic stroke in patients aged 80 years or older
- Evaluation of clinical outcomes and prognostic factors in patients with metastatic appendiceal adenocarcinoma treated with first-line chemotherapy: A multi-institutional retrospective study
BibTeX
@article{gao2026advanced,
title = {{Advanced Lung Cancer Inflammation Index as a Prognostic Inflammation–Nutrition Marker in Appendiceal High‐Grade Pseudomyxoma Peritonei: A 10‐Year Single‐Center Study}},
author = {Yun Gao and Ruiqing Ma and Zhenhai Feng and Siyi Yang and Guangyu An},
journal = {Anz Journal of Surgery},
year = {2026},
month = jul,
doi = {10.1111/ans.70884},
url = {https://doi.org/10.1111/ans.70884},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Advanced Lung Cancer Inflammation Index as a Prognostic Inflammation–Nutrition Marker in Appendiceal High‐Grade Pseudomyxoma Peritonei: A 10‐Year Single‐Center Study
AU - Yun Gao
AU - Ruiqing Ma
AU - Zhenhai Feng
AU - Siyi Yang
AU - Guangyu An
PY - 2026
DA - 2026/07/26
JO - Anz Journal of Surgery
DO - 10.1111/ans.70884
UR - https://doi.org/10.1111/ans.70884
AB - Background: Pseudomyxoma peritonei (PMP) prognosis remains heterogeneous. Systemic inflammation and nutrition are linked to cancer survival, but their role in PMP is unclear. We aimed to evaluate the prognostic impact of inflammation–nutrition status in appendiceal high‐grade PMP and to develop and internally validate a perioperative prognostic model. Methods: We retrospectively included patients with pathologically confirmed appendiceal high‐grade PMP who underwent cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC) between January 2015 and December 2024. Baseline variables included demographics, body mass index (BMI), tumor markers (CEA, CA19‐9, CA125), inflammation–nutrition indices (advanced lung cancer inflammation index [ALI], prognostic nutritional index [PNI], neutrophil‐to‐lymphocyte ratio [NLR], platelet‐to‐lymphocyte ratio [PLR], lymphocyte‐to‐monocyte ratio [LMR], systemic inflammation score [SIS], systemic immune–inflammation index [SII]), prior surgical score (PSS), peritoneal cancer index (PCI), completeness of cytoreduction (CC), HIPEC, pathological subtype, and Ki‐67. Overall survival (OS) was the primary endpoint. Prognostic factors were identified by univariable and multivariable Cox models, and a nomogram was developed and internally validated. Results: Among 223 patients (146 females, 65.5%), median age was 59 years, and median OS was 21 months. In the multivariable Cox regression model, independent risk factors for worse overall survival (OS) were high‐grade with signet‐ring cells (hazard ratio [HR] = 2.575, 95% CI 1.749–3.790; p < 0.001), elevated CA19‐9 (HR = 2.189, 95% CI 1.501–3.192; p < 0.001), elevated CA125 (HR = 1.495, 95% CI 1.050–2.127; p = 0.026), high Ki‐67 (HR = 1.976, 95% CI 1.238–3.154; p = 0.004), and an unfavorable CC (CC1–3) (HR = 2.705, 95% CI 1.295–5.648; p = 0.008), while receipt of hyperthermic intraperitoneal chemotherapy (HIPEC) (HR = 0.611, 95% CI 0.377–0.991; p = 0.046) and a high ALI (HR = 0.576, 95% CI 0.398–0.834; p = 0.003) were independent protective factors. The model achieved a C‐index of 0.753, with 1‐, 2‐, and 3‐year AUCs of 0.810, 0.839, and 0.775, respectively. Calibration error was low (≈3%–6%) and decision‐curve analysis showed sustained net benefit across broad threshold ranges. Conclusions: The ALI is an independent prognostic marker in appendiceal high‐grade PMP. A nomogram incorporating ALI with tumor and pathological variables enabled reliable perioperative survival prediction with strong discrimination, calibration, and clinical utility.
SN - 1445-1433
SN - 1445-2197
ER -